SB 191 establishes a state-run pilot program for psychedelic-assisted therapy using MDMA and psilocybin, effective July 1, 2026. It directly affects qualified patients in Connecticut who are 18+ and meet specific criteria (veterans, retired first responders, or healthcare workers), providing them access to therapy administered by a state-selected medical school. The program requires federal FDA approval under 21 CFR 312 for research purposes and will terminate once MDMA/psilocybin receive DEA approval for medical use. The bill repeals an existing statute and creates a structured framework for this therapeutic pilot program.
This bill restricts most Connecticut hospitals from selling and leasing back their main campus property (a "sale-leaseback") after October 1, 2026, except for hospitals in financial distress that obtain board approval and notify the state health commissioner and attorney general. It requires all hospitals to annually submit a written attestation confirming no private equity firm controls the hospital or interferes with clinical decisions, such as patient care timing, discharge policies, or medical diagnoses. The attestation must cover specific areas like emergency department triage, patient discharge decisions, and medical record entries. Hospitals must use a standard form developed by the state health commissioner to comply.
This bill requires healthcare facilities and schools to cover medical costs and pay full salary for staff injured during work-related assaults or aggressive incidents. It creates a system for reporting patient violence in digital health records (with patient appeal options) and ensures absences due to such incidents don’t count against paid leave. Directly affects healthcare workers, teachers, and school staff who face workplace violence while performing job duties.
HB 5044 establishes Connecticut's official vaccine standards for children and infants, requiring the Commissioner of Public Health to create and maintain a standard of care based on CDC and medical association guidelines. This standard, posted online, will guide vaccination schedules and safety protocols, and must be updated as needed. The bill also mandates a state immunization program that provides free vaccines to healthcare providers for children, distributes vaccination schedules to parents at hospital discharge, and develops outreach to help children who fall behind on immunizations. It directly affects children (especially infants), healthcare providers, hospitals, and public health departments. The program must use available state and federal funds to support these services without creating new state regulations.
This bill requires health insurance plans and Medicaid to cover a twelve-month supply of prescription contraception and hormone therapy at one time, effective January 1, 2027. It applies to individuals with private insurance and Medicaid enrollees, allowing them to receive up to one year of medication and administration supplies in a single dispensation unless they or their provider request less. The law excludes certain drugs like glucagon-like peptide-1 agonists from hormone therapy coverage and permits health plans to use standard drug management rules, including limiting refills near the end of a plan year if the full supply was already provided.
